Acta Chimica Sinica ›› 2007, Vol. 65 ›› Issue (9): 821-828. Previous Articles     Next Articles

Original Articles

金纳米微粒作探针共振瑞利散射法测定某些蒽环类抗癌药物

鲁群岷, 刘忠芳, 刘绍璞*   

  1. (西南大学化学化工学院 重庆 400715)
  • 投稿日期:2006-08-02 修回日期:2006-12-31 发布日期:2007-05-14
  • 通讯作者: 刘绍璞

Resonance Rayleigh Scattering Method for the Determination of Some Anthracycline Anticancer Drugs with Gold Nanoparticle as Probe

LU Qun-Min; LIU Zhong-Fang; LIU Shao-Pu*   

  1. (School of Chemistry and Chemical Engineering, Southwest China University, Chongqing 400715)
  • Received:2006-08-02 Revised:2006-12-31 Published:2007-05-14
  • Contact: LIU Shao-Pu

In a neutral or weak alkaline medium, the gold nanoparticle can combine with an anthracycline anticancer drugs such as epirubicin, daunorubicin or mitoxantrone by the virtue of electrostatic and hydrophobic interaction, forming aggregate with bigger diameters. As a result, the resonance Rayleigh scattering (RRS) was enhanced greatly, and a new RRS spectrum appeared. The maximum RRS signals of three ion-association complexes were all located at about 313 nm, and there were another wide scattering strip between 510~610 nm. There was a linear relationship between the RRS intensity and the drug concentration in the range of 0.009~0.5 for epirubicin (EPI), 0.010~0.7 for daunorubicin (DNR) and 0.030~1.2 mg•mL-1 for mitoxantrone (MXT), respectively. Their detection limits (3σ) for three drugs were 2.7 for epirubicin, 3.1 for daunorubicin and 9.0 ng•mL-1 for mitoxantrone. In this work, the characteristics of the absorption, fluorescence and RRS spectra, the optimum conditions of the reaction and the properties of analytical chemistry were investigated. A sensitive, simple and new method for the determination of anthracycline anticancer drugs based on RRS has been developed.

Key words: gold nanoparticle, resonance Rayleigh scattering, anthracycline anticancer drug